Advertisement

Topics

Chembio Diagnostics Company Profile

12:38 EST 10th December 2018 | BioPortfolio

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Chembio's focus is on developing, manufacturing and marketing tests for the rapid, simple and cost-effective detection of HIV, Tuberculosis (human and veterinary), and certain other Neglected Diseases. Chembio has a proven commitment toward ensuring sustainable supplies of high quality rapid tests to those who need them by using innovative, socially responsible strategies.


News Articles [329 Associated News Articles listed on BioPortfolio]

Chembio nets $15mm via FOPO

Infectious disease-focused Chembio Diagnostics Inc. netted $15mm through a registered public offering of 2.37mm common shares at $6.75. Chembio will use the proceeds to fund its proposed $5.5mm acquis...

Chembio to buy OpTricon for $5.5M, commences $25M offering

Chembio Diagnostics will pay $5.5 million in cash for Germany-based OpTricon, which makes handheld analyzers for rapid diagno -More- 

Chembio Dx announces pricing of stock offering

A public offering of approximately 2.4 million shares of common stock has been priced by Chembio Diagnostics at $6.75 each.  -More- 

Chembio Dx appoints new board member

Mary Lake Polan, a professor at the Yale School of Medicine, has been tapped by Chembio Diagnostic Systems to serve on its bo -More- 

FIND, Chembio partner to explore point-of-care HCV testing

Chembio Diagnostic Systems' Dual Path Platform technology will be used to assess the feasibility of a rapid hepatitis C virus -More- 

Chembio Diagnostics, Inc. (CEMI) CEO John Sperzel on Q2 Results - Earnings Call Transcript

Chembio Diagnostics, Inc. (CEMI) CEO John Sperzel on Q3 2018 Results - Earnings Call Transcript

Chembio secures FDA EUA authorization for Ebola virus diagnostic test

Chembio said the EUA status has been provided for the DPP Ebola antigen system for use with human capillary fingerstick whole blood, EDTA venous whole blood and EDTA The post Chembio secures FDA EUA ...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [218 Associated PubMed Articles listed on BioPortfolio]

Dizziness and vertigo associated with vestibular neuronitis: the approaches to the diagnostics and treatment.

This article is focused on the peculiar features of diagnostics and treatment of dizziness and vertigo in the patients presenting with vestibular neuronitis. The authors present the detailed overview ...

Statistical primer: checking model assumptions with regression diagnostics.

Regression modelling is an important statistical tool frequently utilized by cardiothoracic surgeons. However, these models-including linear, logistic and Cox proportional hazards regression-rely on c...

SwissFEL Aramis beamline photon diagnostics.

The SwissFEL Aramis beamline, covering the photon energies between 1.77 keV and 12.7 keV, features a suite of online photon diagnostics tools to help both users and FEL operators in analysing data...

Differentiated laboratory diagnostics of rheumatic diseases.

Laboratory diagnostics of rheumatic diseases include examinations to confirm the diagnosis, estimate prognosis, assess disease activity as well as recognition and avoidance of complications. Although ...

A paradigm shift for prostate cancer diagnostics.

The current praxis of diagnosing prostate cancer, with systematic prostate biopsies in men with raised serum prostate-specific antigen (PSA) levels, leads to considerable over-diagnosis and over-treat...

Clinical Trials [229 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in ...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

Companies [940 Associated Companies listed on BioPortfolio]

Chembio Diagnostics

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Ch...

Chembio Diagnostic Systems Incorporated

Chembio Diagnostic Systems, Inc., is a U.S. biotechnology company located in Medford, New York. The company discovers, develops, manufactures and markets rapid immunodiagnostic tests. Chembio's rapid ...

Chembio Diagnostic Systems, Inc.

Chembio Diagnostic Systems, Inc. is a US company serving the increasing global demand for rapid tests needed for the effective prevention and treatment of infectious diseases, and other conditions. Ch...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

More Information about "Chembio Diagnostics" on BioPortfolio

We have published hundreds of Chembio Diagnostics news stories on BioPortfolio along with dozens of Chembio Diagnostics Clinical Trials and PubMed Articles about Chembio Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chembio Diagnostics Companies in our database. You can also find out about relevant Chembio Diagnostics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record